Skip to main content
Erschienen in:

Open Access 01.12.2025 | Research

Explainable machine learning models for identifying mild cognitive impairment in older patients with chronic pain

verfasst von: Xiaoang Zhang, Yuping Liao, Daying Zhang, Weichen Liu, Zhijian Wang, Yaxin Jin, Shushu Chen, Jianmei Wei

Erschienen in: BMC Nursing | Ausgabe 1/2025

Abstract

Background

Mild cognitive impairment (MCI) is prevalent in older adults with chronic pain, making early detection crucial for dementia prevention and healthy aging. This study aimed to determine MCI risk factors in older patients with chronic pain and to develop 9 machine learning models to identify MCI risk.

Methods

A total of 612 older patients with chronic pain were recruited between October 2023 and July 2024. Data collected included patients’ general information, cognitive function, pain level, depression, and sleep quality. The dataset was randomly divided into training set and testing set, and processed by Min-Max Normalization and SMOTETomek comprehensive sampling. SVM-RFE and LASSO regression were used for variable selection. We then developed machine learning models and interpreted them by SHAP.

Results

Age, education level, number of pain sites, pain duration, pain level, depression and sleep quality were risk factors of MCI in older patients with chronic pain. The Extreme Gradient Boosting (XGBoost) model performed best (AUC 0.925), with pain level, age, and depression as the most important variables.

Conclusions

We successfully developed 9 machine learning models to identify MCI risk. These models provide a tool for nurses to detect MCI risk early. We recommend that nurses integrate machine learning techniques into clinical nursing practice for managing MCI. However, these findings require validation with longitudinal data to confirm predictive validity for MCI progression.
Hinweise

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

The global older population is projected to double to 1.5 billion by 2050 [1], with China facing significant aging challenges. By 2021, China had 264 million older adults, expected to comprise a quarter of its population by 2025 [2]. Chronic pain is one of the prevalent and costly health problems in older adults that limits mobility and reduces quality of life [3]. Studies have shown that the incidence of chronic pain among older adults is significantly higher than in the general population, about 40-80%, and this proportion rises with age [4]. Given China’s large aging population and high chronic pain prevalence, greater attention is needed for this group.
Mild cognitive impairment (MCI) is a transition state from normal cognitive aging to dementia. It is characterized by a progressive decline in cognitive function that does not meet criteria for the diagnosis of dementia and is the best “window of intervention” for dementia prevention [5]. Older adults are at high risk of developing MCI, and those with chronic pain are at an even higher risk of cognitive impairment, with prevalence exceeding 50% [6]. Moreover, chronic pain and MCI often interact, increasing dementia risk [3]. Fortunately, MCI has the potential to reverse [5], making early detection in older adults with chronic pain critical for healthy aging. The US Preventive Services Task Force also recommends early prevention of MCI and optimizing assessment tools [7].
Common MCI assessment tools like the Mini-Mental State Examination (MMSE), Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), Montreal Cognitive Assessment Scale (MoCA), and Self-administered Dementia Screening Questionnaire (p-AD8) are valuable, and annual cognitive health assessments are recommended for older adults [8]. However, 29%-76% of people with cognitive impairment fail to be diagnosed promptly, making early prevention of MCI a challenge [9]. These tools are time-consuming and their cut-off values need to be further clarified [5]. Moreover, traditional methods, based on neuropsychological tests, often result in later-stage diagnoses [10]. Prediction models enable earlier identification of high-risk individuals by integrating specific MCI risk factors, thus addressing the limitation of late diagnosis in traditional tools and providing a more comprehensive and targeted assessment. Therefore, developing such models for older patients with chronic pain are upstream approaches to preventing MCI.
Previous studies have explored the complex relationship between chronic pain and MCI, but few have focused on identifying MCI risk in older patients with chronic pain. Although many risk factors for MCI in older adults are worth considering [11], this needs further validation in this specific subgroup. Moreover, it remains unclear which variables have higher predictive value. Although MCI prediction models have been developed for older patients with diabetes and chronic kidney disease, etc [12, 13]. , no such models exist for older patients with chronic pain. Besides, most existing models rely on logistic regression methods, and their accuracy and practicality require further optimization.
Machine learning has shown its strong potential in identifying MCI risk. Unlike traditional methods, it can uncover hidden relationships between risk factors and highlighting the most predictive ones [14]. However, the lack of clarity about the reasons behind machine learning decisions can hinder trust and usability among nurses. To address this, the Shapley Additive Explanations (SHAP) method can show how risk factor influences the model’s identification of MCI risk [10]. Specifically, SHAP method highlights the most important variables for MCI risk and explain how a single variable, such as pain level or age, or all included variables, affect MCI risk for each individual. SHAP makes it easier for nurses to use machine learning models in clinical settings by explaining the results of MCI risk and variables analyzed by the model in a way that nurses can understand, helping them better assess MCI risk and develop personalized care plans that target specific risk factors early, thereby improving patient outcomes [10].
Therefore, this study aims to determine MCI risk factors in older adults with chronic pain and develop explainable machine learning models to identify MCI risk. The findings will help nurses detect high-risk patients early and develop personalized care strategies to reduce MCI incidence.

Methods

Study design

This cross-sectional study collected data through face-to-face interviews with older patients with chronic pain, including general data, pain level, depression, sleep quality, and MCI. We then developed 9 machine learning models to identify MCI risk and interpreted the best model using the SHAP method. The report of this study complies with the TRIPOD statement [15].

Participants and sample size

In this study, 612 older patients with chronic pain were recruited from the Pain Department of a tertiary general hospital in Nanchang, China, between October 2023 and July 2024 using convenience sampling. Inclusion criteria: (1) aged ≥ 60 years; (2) meet the International Association for the Study of Pain (IASP) diagnostic criteria for chronic pain, that is, pain duration ≥ 3 months, daily or almost daily pain, visual analogue scale ≥ 3 points [16]; (3) able to communicate and understand the questionnaire. Exclusion criteria: (1) suffering from malignant tumors; (2) severe neurological, hematological, or immune diseases; (3) severe dysfunction of major organs such as heart, kidney, or liver; (4) being diagnosed with dementia.
Sample size was calculated based on the principle that event per variable (EPV) ≥ 10 [17]. 16 variables were expected to be included in this study, considering a loss to follow-up rate of 10%-20%, so the minimum sample size for modeling was 178. Since the modeled sample size represents 70% of the total sample, the total sample size is at least 255. A total of 612 patients were finally included and met this requirement.

Ethical considerations

The study was approved by the Medical Ethics Committee of the 1st Affiliated Hospital of Nanchang University (IIT2023461) and was conducted in accordance with the Declaration of Helsinki. All participants voluntarily agreed to participate and signed an informed consent form, and their personal information was anonymized. They were also informed of their right to refuse participation in the study at any stage.

Instruments

We selected clinically important variables based on panel discussions, literature review, and expert consultation. In order to ensure the rationality of variable selection, these variables were confirmed by two experts before inclusion.
Measures of outcomes.
The outcome of this study was the occurrence of MCI, which was diagnosed according to Petersen’s Criteria and the International Working Group on MCI [18, 19]. The diagnostic criteria included: (1) subjectively reported memory loss lasting 3 months or more; (2) Montreal Cognitive Assessment Scale (MoCA) score < 26; (3) normal or mildly impaired activities of daily living (ADL) level, that is, ADL scale score < 22; (4) not meeting the diagnostic criteria for dementia as assessed by the Mini-Mental State Examination (MMSE); and (5) no special cause that may lead to cognitive decline. Patients meeting all 5 of the above criteria were diagnosed with MCI. A senior neurologist confirmed the final diagnosis.
MoCA is widely used internationally to assess cognitive function [19]. It has 8 cognitive domains, including executive function, visuospatial, memory, attention, language, abstract thinking, naming, and orientation. The total score ranges from 0 to 30, with higher scores indicating better cognitive function. A score ≥ 26 indicates normal cognitive function, and a score < 26 suggests MCI.
The MMSE was developed by Folstein et al. [20] to assess dementia. It consists of 5 dimensions: orientation, memory, attention and calculation, visual construction, and language, with a total score ranging from 0 to 30. Illiterate individuals scored < 17, individuals scored < 20 for primary school culture, individuals scored < 22 for secondary school culture, and individuals scored < 23 for university culture suggesting the presence of dementia.
The ADL scale was developed by Lawton and Brody [21] to assess the level of independence in ADL. It consists of 14 items with a total score ranging from 14 to 56. Higher scores indicate lower functional independence. A score of 14 indicates normal independence in ADL, and a score of 15–22 indicates mildly impaired independence in ADL.

Measurement of variables

We developed a general data questionnaire for the collection of demographics and disease-related characteristics. The questionnaire consists of 13 items, including: age, sex, education level, monthly household income, body mass index (BMI), employment status, marital status, living arrangement, smoking, alcohol consumption, number of pain sites, pain characteristics (for multiple pain characteristics, pain characteristics was determined based on their primary complaint, defined as the most bothersome pain characteristic that best represented themselves), and pain duration (for multiple pain sites, the longest pain duration was recorded).
Visual analogue scale (VAS) was used to assess pain level [22]. Participants were asked to rate their average pain intensity over the past week. When using, place the graduated side of the ruler back toward the patient, having the patient mark the location on the ruler that best represents their average pain level in the past week, and then the assessor assesses the score according to the location of the mark. VAS total scores range from 0 (none) to 10 (very), with higher scores indicating more severe pain.
The 15-item geriatric depression scale (GDS-15), developed by Yesavage et al. [23], assesses depression in older adults. The scale consists of 15 items, each scored 0 or 1, and the total score ranges from 0 to 15, with higher scores indicating more severe depression. A score of 0–4 indicates no depression, 5–8 indicates mild depression, 9–11 indicates moderate depression, and 12–15 indicates severe depression.
The Pittsburgh Sleep Quality Index (PSQI) was developed by Buysse et al. [24] to assess sleep quality. The scale includes 19 self-rated items and 5 other-rated items, with total scores ranging from 0 to 21. Higher scores indicate poorer sleep quality.

Data collection

Prior to data collection, we set up a research team and uniformly trained the panelists. Only those passing the assessment conducted data collection. Patients were fully informed about the study and had sufficient time to decide whether to participate.
Data were collected through face-to-face interviews using standardized instructions in the hospital classroom or ward. The primary purpose of the interviews was to help participants accurately complete the questionnaire. In order to minimize the risk that face-to-face interactions might influence the responses of participants, interviewers were trained to provide neutral assistance and avoid any form of guidance or suggestion that could sway participants’ answers. Participants were encouraged to answer honestly; their questions or doubts were cleared promptly. For those unable to complete the questionnaire independently, interviewers provided explanations and completed the questionnaire on their behalf. Completed questionnaires were collected immediately.
Afterward, we conducted a rigorous questionnaire review and excluded those invalid questionnaires with logic error, and regular answers. To ensure accuracy, all data were cross-checked by two persons before entry, and 10% of the data were regularly reviewed. A total of 635 questionnaires were distributed, and 612 were valid, with an effective recovery rate of 96.4%.

Statistical analysis

Statistical analysis was performed using SPSS 25.0 and Python 3.11, with P < 0.05 was considered statistically significant. Normally distributed measurement data are expressed as mean ± standard deviation (M ± SD), non-normally distributed measurement data as median and quartile, and the enumeration data are expressed as frequency and percentage. The t-test and Mann-Whitney U test were used to compare the measurement data, and chi-square test was used to compare enumeration data.
First, we preprocessed the data. Since no missing data were identified in the study, the dataset was randomly divided into a training set (70%) and a testing set (30%). The training set was used to develop the model, while the testing set was used to evaluate and interpret the model. The Min-Max Normalization method was used to normalize data to the range of 0–1. Considering the potential linear and nonlinear relationships between MCI and variables in our cross-sectional data, we used LASSO and Support Vector Machine-Recursive Feature Elimination (SVM-RFE) for variable selection. LASSO assumes a linear relationship between MCI and variables and selects variables by reducing irrelevant coefficients to zero, while SVM-RFE ranks the importance of variables to capture nonlinear relationships. This complementary approach ensures the variables selected are both statistically robust and clinically relevant, enhancing model’s interpretability [14]. Given the small number of MCI-positive samples in our study, SMOTETomek comprehensive sampling was used to balance the data. SMOTETomek generates synthetic samples for the minority class (MCI-positive cases) by interpolating between existing samples, achieving a 1:1 balance between MCI-positive and non-MCI cases, which improves model accuracy and reducing bias in detecting MCI [25].
After data processing, we developed 9 machine learning models [14]. These models included Logistic Regression (LR), Adaptive Boosting (AdaBoost), Support Vector Machine (SVM), eXtreme Gradient Boosting (XGBoost), K-Nearest Neighbors (KNN), Stacking, Gradient Boosting Decision Tree (GBDT), Random Fores (RF), and Light Gradient Boosting Machine (LightGBM). These models were selected for their diverse representation of machine learning approaches, encompassing single, ensemble, and probabilistic models. All suited for analyzing MCI risk factors in cross-sectional data. Specifically, AdaBoost identifies MCI risk by focusing more on hard-to-analyze risk factors. SVM is good at analyzing the complex relationships among MCI risk factors. KNN flexibly handles both continuous and categorical variables (e.g., age and education level) contained in our MCI dataset. LightGBM, RF, XGBoost, and GBDT excel at handling our large, multivariate MCI dataset. Stacking can comprehensively explore the linear and nonlinear relationships between MCI and variables. Hyperparameters were tuned using grid search to optimize performance. Model’s evaluation metrics included accuracy (proportion of correct predictions), precision (true positive rate among predicted positives), recall (true positive rate among actual positives), F1 values (balance of precision and recall), specificity (true negative rate), sensitivity (true positive rate), Receiver Operating Characteristic (ROC) curves, Area Under the Curve (AUC), Calibration curves, and Brier scores (probabilistic accuracy), and Decision curves analysis (DCA) [14]. AUC differences between models were compared using DeLong’s test. To minimize random errors, all metrics were calculated using 10-fold cross validation. Finally, to enhance interpretability, the SHAP method was used to assess variable importance and analyze how variables influenced MCI risk [10].

Results

Characteristics of patients

A total of 612 patients were included in this study, 169 (27.6%) of whom were classified as MCI; 250 (40.8%) were male and 362 (59.2%) were female. The mean age of the patients was (71.13 ± 6.11) years, mean BMI was (24.05 ± 4.55) kg/m2, mean pain duration was (9.53 ± 3.79) months, mean VAS was (7.74 ± 1.31), mean GDS-15 was (4.90 ± 1.77), and mean PSQI was (8.63 ± 4.20). Patient characteristics are detailed in Table 1. Compared to the non-MCI group, patients in the MCI group were older, had lower education level, more pain sites, more severe pain, longer pain duration, and poorer sleep quality; they were also more likely to be without a spouse, smoke, consume alcohol, and experience depression. These differences were statistically significant.
Table 1
Comparison of characteristics between the two groups (N = 612)
Characteristic
MCI
Non-MCI
t /z/c2
P-value
(n=169)
(n=443)
Age (years old)
    
Mean (SD)
77.60±4.659
68.67±4.606
-21.27
<0.001
Gender
    
 Male
71 (42.0%)
179 (40.4%)
0.131
0.718
 Female
98 (58.0%)
264 (59.6%)
  
Educational level
    
 Primary school or below
82 (48.5%)
123 (27.8%)
65.666
<0.001
 Junior high school
58 (34.3%)
128 (28.9%)
  
 High school
17 (10.1%)
109 (24.6%)
  
 University or above
12 (7.1%)
83 (18.7%)
  
Monthly household income (CNY)
    
 < 3000
32 (18.9%)
100 (22.6%)
1.661
0.646
 3000–5000
75 (44.4%)
202 (45.6%)
  
 5000–10,000
40 (23.7%)
91 (20.5%)
  
 > 10,000
22 (13.0%)
50 (11.3%)
  
BMI
    
 Underweight
22 (13.1%)
73 (16.5%)
2.419
0.298
 Normal
79 (46.7%)
219 (49.4%)
  
 Overweight or obese
68 (40.2%)
151 (34.1%)
  
Employment status
    
 Unemployment/Retirement
103 (60.9%)
295 (66.6%)
1.714
0.19
 Employed
66 (39.1%)
148 (33.4%)
  
Marital status
    
 Unmarried/widowed/divorced
42 (24.9%)
72 (16.3%)
5.968
0.015
 Married
127 (75.1%)
371 (83.7%)
  
Living arrangements
    
 Live alone
55 (32.5%)
115 (26.0%)
2.644
0.104
 Live with family
114 (67.5%)
328 (74.0%)
  
Smoking
    
 No
66 (39.1%)
293 (66.1%)
37.012
<0.001
 Yes
103 (60.9%)
150 (33.9%)
  
Alcohol consumption
    
 No
90 (53.3%)
234 (52.8%)
8.492
0.014
 Responsible drinking
50 (29.6%)
167 (37.7%)
  
 Alcohol abuse
29 (17.1%)
42 (9.5%)
  
Number of pain sites
    
 1 – 2
67 (39.6%)
217 (49.0%)
7.132
0.028
 3 – 4
62 (36.7%)
158 (35.7%)
  
 ≥5
40 (23.7%)
68 (15.3%)
  
Pain characteristics
    
 Stabbing pain
62 (36.7%)
165 (37.2%)
2.2
0.532
 Cutting pain
33 (19.5%)
107 (24.2%)
  
 Burning pain
44 (26.0%)
107 (24.2%)
  
 Bloating pain
30 (17.8%)
64 (14.4%)
  
Pain duration (month)
    
 3-6
23 (13.6%)
147 (33.2%)
53.116
<0.001
 7-11
61 (36.1%)
200 (45.1%)
  
 ≥12
85 (50.3%)
96 (21.7%)
  
Pain level
    
 Mean (SD)
8.46±1.134
7.47±1.268
-9.347
<0.001
Depression
    
 Mean (SD)
5.69±1.887
4.59±1.619
-7.16
<0.001
Sleep quality
    
 Mean (SD)
12.59±3.626
7.12±3.323
-17.762
<0.001
SD: Standard Deviation

Preprocessing of data and screening of variables

We divided 428 samples (70%) into the training set, and 184 (30%) samples into the testing set. There were no significant differences in the candidate variables between the two groups (P > 0.05). To screen key variables, we combined LASSO regression and SVM-RFE. LASSO regression identified variables with the smallest mean square error (MSE) when Log(λ) = -3.554, which included age, education level, smoking, number of pain sites, pain duration, pain level, depression, and sleep quality, as shown in Fig. 1A and B. For SVM-RFE, SVM models including 9 variables (pain level, depression, age, education level, number of pain sites, pain duration, sleep quality, alcohol consumption, BMI) had the highest accuracy, as shown in Fig. 1C. By intersecting the results of both methods, the final selected variables were: age, education level, pain duration, number of pain sites, pain level, depression, sleep quality, as shown in Fig. 1D. After using SMOTETomek comprehensive sampling technique, both MCI and non-MCI sample sizes in the training set reached 313, achieving a balance of data.

Model performance

We developed 9 machine learning models and optimized their hyperparameters by grid search. Table 2 shows the performance of each model on the testing set, among which the XGBoost model performed best, achieving an accuracy of 0.883 and an AUC of 0.925 (95% CI 0.863–0.995). The high accuracy (> 0.850), high AUC (> 0.900), and other performance metrics indicate that XGBoost is highly effective in accurately identifying MCI risk and distinguishing patients with MCI from those without. DeLong’s test showed that XGBoost’s AUC was significantly higher than the others (P < 0.05). Figure 2A and B more visually depict the contrast of model performance. Figure 2C shows that XGBoost’s ROC curve (red line) enclosed the largest AUC. Figure 2D presents the calibration curve, highlighting XGBoost’s lowest Brier score and the strongest agreement between predicted and actual MCI probabilities. Figure 2E depicts the DCA, where XGBoost has the largest net benefit over most threshold probability ranges and is most helpful for nurses to make clinical decisions. Therefore, the XGBoost model was selected as the best model for further analysis.
Table 2
Comparison of prediction performance of 9 machine learning models
Models
Accuracy
Precision
Recall
F1 value
Specificity
Sensitivity
AUC(95%CI)
LR*
0.840
0.814
0.882
0.847
0.799
0.882
0.895(0.829–0.966)
AdaBoost *
0.712
0.646
0.939
0.766
0.686
0.939
0.868(0.770–0.972)
SVM *
0.696
0.668
0.783
0.721
0.610
0.783
0.757(0.672–0.844)
XGBoost
0.883
0.882
0.885
0.884
0.882
0.885
0.925(0.863–0.995)
KNN *
0.748
0.734
0.776
0.755
0.719
0.776
0.853(0.728–0.985)
Stacking *
0.840
0.814
0.882
0.847
0.799
0.882
0.828(0.734–0.920)
GBDT *
0.807
0.793
0.831
0.811
0.783
0.831
0.811(0.680–0.946)
RF *
0.813
0.818
0.805
0.812
0.821
0.805
0.861(0.749–0.968)
LightGBM*
0.813
0.804
0.842
0.802
0.817
0.843
0.836(0.704–0.973)
*: Compared with XGBoost, the difference in AUC was statistically significant, P < 0.05

Model interpretation

We interpret the output of the XGBoost model by the SHAP method. Figure 3A is the SHAP feature importance plot, which ranks the 7 variables by importance. It shows that pain level, age, and depression are the 3 most important variables for MCI risk. The SHAP summary plot in Fig. 3B shows the effect of each variable on MCI risk, with pain level being the most important variable positively associated with MCI risk and education level being the most important variable negatively associated with MCI risk. Figure 3C is the SHAP decision plot, which highlights the impact of variables on the model’s decision to classify each patient into the high- or low-risk group for MCI. Figure 4A and B are SHAP waterfall plots for high-risk and low-risk MCI patients, respectively, detailing the contribution of each variable. Specifically, age 79 years, VAS score 8, PSQI score 13, pain at 3–4 sites, and GDS-15 score 5 increased MCI risk; while education level at university or above, pain lasting 3–6 months, age 63 years, GDS-15 score 1, pain at 1–2 sites, and PSQI score 1 reduced MCI risk, even if VAS score was as high as 9. The decision plot in Fig. 4C further demonstrates how variables affect the model’s decision-making process of classifying two patients into high- and low-risk groups.
Figure 5 presents SHAP dependence plots, revealing non-linear relationships between variables and MCI risk. Overall, MCI risk increased with higher pain levels, older age, greater depression, and more pain sites, while higher education levels and improved sleep quality decreased MCI risk. In addition, MCI risk changed in an inverted “U” pattern with increasing pain duration. To further enhance the clinical utility of the SHAP method in nursing practice, we developed an overview table summarizing MCI risk assessment and management strategies for nurses (Table 3).
Table 3
SHAP-Identified variables and their clinical implications
Variable
Importance Ranking
Effect on MCI Risk
Suggested Nursing Actions
Pain level
1
Increases with severity.
Routine pain assessments; implement multimodal pain management strategies.
Age
2
Increases with advancing age.
Prioritize cognitive screening for older patients; provide age-appropriate care plans.
Depression
3
Increases with severity.
Regular depression screenings; provide access to counseling and psychological care.
Education level
4
Decreases as education level increases.
Provide health education; promote active learning; involve families in cognitive management.
Pain duration
5
Increases with duration, peaks at 1 year, then decreases slightly.
Monitor long-term pain; provide early pain management; encourage pain self-care.
Sleep quality
6
Decreases with improvement.
Strengthen sleep monitoring; educate on sleep hygiene; recommend relaxation techniques.
Number of pain sites
7
Increases with more sites.
Comprehensive pain assessment; prioritize multisite pain management.

Discussion

This study aimed to enhance the cognitive health of older patients with chronic pain by identifying risk factors for MCI and developing explainable machine learning models for MCI risk assessment. We determined 7 variables significantly associated with MCI: pain level, age, depression, education level, pain duration, sleep quality, number of pain sites. The XGBoost model performed best, with pain level, age, and depression identified as the three most important variables. The prediction model developed in this study offers nurses with a practical tool for early and individualized MCI risk assessment, and identified risk factors can serve as the focus of targeted assessment and intervention in nursing practice.
This study showed that the incidence of MCI in older patients with chronic pain was 27.6%, higher than the global average for the older population (15.5%) but lower than the 54.4% reported by Moriya et al. in chronic pain clinics [3, 26]. This may stem from differences in sample size and assessment methods. Nevertheless, cognitive issues in this population warrant greater attention. On the one hand, healthcare providers pay significantly insufficient attention to their cognitive impairment, with actual clinical diagnosis rates below 5% [6]. On the other hand, both chronic pain and MCI can be mitigated by intervention [27], emphasizing the necessity of early identification of high-risk patients for developing care strategies.
Consistent with previous findings [11], this study confirms a positive association between age and MCI risk. The SHAP feature importance plot further identified age as the second most important variable for MCI risk. This is not surprising, as aging is closely linked to numerous risk factors. Advanced age exacerbates the interaction between chronic pain, white matter hyperintensities (WMH), and hippocampal atrophy and increases the likelihood of multiple chronic comorbidities [28]. Aging also often leads to diminished social capabilities, further compounding MCI risk [29]. Therefore, nurses should focus on cognitive screening and follow-up plans tailored to different age groups, while enhancing chronic disease management and psychosocial support. This study also showed that patients with lower education levels were more likely to develop MCI, consistent with previous research [30]. This may be due to reduced synaptic density in the cerebral cortex and insufficient stimulation of brain cells, which hinder the maintenance of cognitive function [11]. Given that more than 65% of patients in this study had an education level of primary school or below, nurses should implement health education programs, encourage patients to engage in lifelong learning, and guide family members to participate in cognitive health management efforts.
This study identified pain level as the most important variable positively associated with MCI risk, as highlighted by SHAP feature importance analysis. This novel finding can be explained by existing research [31]. Chronic pain has been associated with alterations in the cerebral cortex and gray matter, and elevated cortisol levels, which impair hippocampal synaptic plasticity. Chronic pain, the most common symptom of patients, also triggers a cascade of adverse effects, including depression and activity limitations, often creating a vicious cycle that further deteriorates cognitive function. Notably, we observed an association between the number of pain sites and increased MCI risk, a finding supported by Zhao et al., who reported that chronic pain at multiple sites correlates with more severe cognitive impairment and hippocampal atrophy [32]. In addition, our study found that pain duration was positively associated with MCI risk overall. Interestingly, however, unlike the linear relationship reported in previous study [33], our SHAP dependence plot revealed an inverted “U” curve in the relationship between pain duration and MCI risk, indicating that when pain duration exceeded one year, MCI risk decreased. The “adaptation hypothesis” may offer an explanation for this phenomenon: chronic pain initially induces increased stress and neuroinflammation; however, over time, the brain compensates for sustained pain by utilizing alternative coping mechanisms, leading to psychological adaptation and cognitive resilience, which mitigates cognitive decline [34]. Moreover, as time progresses, the pain and cognitive self-management skills acquired by patients may help reduce MCI risk. Nurses should prioritize comprehensive and regular pain assessments, including assessments of pain level, duration, and number of pain sites. In the early stages of chronic pain, nurses should prioritize cognitive screenings and address potential risk factors for MCI. As pain duration increases, the focus should shift towards maintaining functional independence, enhancing coping strategies, and promoting social engagement to mitigate the long-term cognitive effects of chronic pain.
The SHAP feature importance plot identified depression as the third most important variable associated with MCI risk. This finding aligns with previous research, which has shown that depression contributes to increased cortical amyloid-beta deposition. Moreover, depression and chronic pain often co-occur, and their synergistic effects, compounded by their adverse impact on sleep health, significantly exacerbate cognitive impairment [35]. Our study also confirmed that sleep quality significantly impacts MCI risk, consistent with previous research [36]. Long-term poor sleep quality may reduce acetylcholine and monoamine neurotransmitters levels in the brain, impairing memory and cognitive function [37]. Therefore, regular depression screening and sleep quality monitoring should be integral to cognitive health care strategies. Nurses should promote cognitive behavioral therapy and relaxation techniques to manage depression. Additionally, they should encourage patients to adopt proper sleep hygiene practices, including consistent sleep schedule and minimizing screen exposure before bedtime. However, unlike the findings of Jia et al. [26], this study failed to find a significant association between smoking, alcohol consumption, and MCI. We speculate that the cross-sectional design, which cannot assess temporal causality, along with the small sample size and the rigorous variable selection methods, may have limited our ability to detect these complex relationships. Moreover, hypertension and hyperlipidemia may have mediated their effects on MCI risk, potentially obscuring any direct associations. But given inherent health risks of smoking and alcohol consumption, promoting a healthy lifestyle remains essential.
Given the lack of prediction models for early identification of MCI in older patients with chronic pain, we developed machine learning models to address this gap. Among these, the XGBoost model performed best, with an AUC of 0.925 (95% CI 0.863–0.995). In comparison, Jiang et al.'s traditional diabetes-based MCI prediction model reported an AUC of 0.893 [12], while Huang et al.'s MCI logistic regression model for middle-aged and older adults achieved an AUC of 0.870 [38]. These findings highlight the superiority of machine learning models over traditional approaches, as traditional models often struggle to capture the intricate, nonlinear relationships between MCI and risk factors. XGBoost excels at handling complex, large datasets, effectively capturing both linear and nonlinear associations to enhance MCI prediction accuracy [10], as evidenced by the superior performance observed in our study. Although some traditional models, like Xu et al.'s (AUC 0.897) [13], achieve comparable performance, they can only explain the MCI risk at the overall level and overlook nuanced insights and fail to account for complex interactions between variable like depression and sleep quality, thereby limiting their clinical applicability. By contrast, our SHAP-based machine learning model provides a comprehensive interpretation, offering precise and personalized guidance for clinical practice. For example, using SHAP feature importance plot, we identified pain level, age, and depression as the three most important variables influencing MCI risk in older patients with chronic pain, which had not been reported previously. These results not only highlight priority areas for future MCI research but also offer actionable insights for nursing practice. Nurses can focus MCI prevention efforts on efficient pain management, regular depression screening, and prioritizing care for older adults. SHAP summary, decision, and dependence plots further clarify the individual and combined effects of these critical variables on MCI risk. For example, by identifying patients at high risk due to severe pain or depression, nurses can prioritize these factors and initiate personalized nursing management for pain and psychology early. Moreover, SHAP waterfall plots provide detailed, patient-specific visualizations of MCI risk, enabling nurses to allocate resources more effectively and plan targeted interventions. In contrast, traditional models lack the capability to prioritize risk factors or offer individualized insights, leaving nurses without clear guidance for targeted prevention strategies. In summary, these explainable techniques optimize traditional one-size-fits-all MCI management strategies and demonstrates unique advantages in developing detailed, personalized MCI assessments [25].
This study offers valuable insights for future research and practical applications in nursing. First, identifying MCI risk factors equips nurses with specific indicators for closely monitoring patients and developing targeted interventions. Future studies should examine whether these risk factors apply to specific chronic pain conditions such as trigeminal neuralgia and lumbar disc herniation, thus further refining nursing strategies. Second, as our model was developed using data from the Chinese population, nurses in other regions should validate and adapt the model to ensure its applicability in local settings. Third, we advocate a multidisciplinary approach to the management of MCI and chronic pain. Nurses should work with other healthcare professionals like pain specialists, neurologists, psychologists to develop a comprehensive care plan. Furthermore, this prediction model enables nurses to integrate regular MCI risk screening for older patients with chronic pain into routine assessments. Such proactive approach supports secondary prevention by facilitating early detection and intervention, as well as tertiary prevention by identifying patients at risk of worsening or recurrent MCI, allowing timely adjustments to care plans [26, 39].
To our knowledge, this study is the first to develop machine learning models to identify MCI risk in older patients with chronic pain. The study has several key advantages: First, the integration of LASSO regression and SVM-RFE methods for variable screening ensures more rational variable selection. Most of the selected variables are modifiable, increasing the potential for targeted interventions. Second, we developed 9 representative machine learning models, enhancing the ability to identify MCI. Moreover, we used multiple evaluation metrics to ensure the comprehensive model assessment. Finally, the model is efficient, easy to use, and visualized using the SHAP method, which significantly improves its practical applicability.

Limitation

The cross-sectional design restricts our ability to infer causal relationships between variables and MCI. Longitudinal studies are needed to establish causality. The study population consisted exclusively of Chinese older adults, which may limit the cultural generalizability of the model. The comprehensiveness of cognitive health data varies across healthcare systems, and different cultural attitudes toward pain and cognitive health may affect the reliability of symptom reporting, thereby influencing the model’s performance and usability. Therefore, we recommend that future studies conduct collaborative, multicenter research across diverse populations with different cultural and ethnic backgrounds to validate the model. Given the cross-sectional design of this study, the temporal relationship between medical history and MCI risk could not be fully assessed. Furthermore, since the study primarily focused on pain-related psychosocial factors, variables such as medical history, medication history, comorbidities, and laboratory measures were excluded, which may have influenced the model’s performance. However, the use of non-invasive variables enhances the model’s applicability in community and primary care settings. Furthermore, some variables, such as depression and sleep quality, were based on self-report data, which may introduce biases and affect the reliability of the model. Finally, advanced machine learning algorithms like deep learning were not considered. Future studies should address these limitations.

Conclusion

In conclusion, this study revealed that pain level, age, depression, education level, pain duration, sleep quality, and number of pain sites were risk factors for MCI in older patients with chronic pain. We successfully developed 9 machine learning models to identify MCI risk, with the XGBoost model performing best. Furthermore, we enhanced model’s clinical utility using the SHAP method. These findings offer a tool for nurses to detect MCI risk early and highlight the value of integrating machine learning techniques into nursing practice. However, this study was based on a cross-sectional design, future research should validate these findings using longitudinal data to confirm the model’s predictive validity for MCI progression.

Acknowledgements

Not applicable.

Declarations

This study was approved by the Medical Ethics Committee of the 1st Affiliated Hospital of Nanchang University with the approval number IIT2023461. All participants provided written informed consent prior to their involvement in the study. In the course of the study, we strictly abide by the basic principles of the Declaration of Helsinki, respect and protect the rights and privacy of the participants, and ensure the confidentiality of their personal information.
Informed consent for publication of anonymized data was obtained from all participants involved in the study. No identifying details, images, or videos that could compromise participants’ privacy have been included in the manuscript. If required, copies of the signed consent forms can be made available to the editors upon request.

Competing interests

The authors declare no competing interests.

Clinical trial number

Not applicable.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by-nc-nd/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Yuan Y, Peng C, Burr JA, Lapane KL. Frailty, cognitive impairment, and depressive symptoms in Chinese older adults: an eight-year multi-trajectory analysis. BMC Geriatr. 2023;23(1):843.CrossRefPubMedPubMedCentral Yuan Y, Peng C, Burr JA, Lapane KL. Frailty, cognitive impairment, and depressive symptoms in Chinese older adults: an eight-year multi-trajectory analysis. BMC Geriatr. 2023;23(1):843.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Chang J, Hou W, Li Y, Li S, Zhao K, Wang Y, Hou Y, Sun Q. Prevalence and associated factors of cognitive frailty in older patients with chronic kidney disease: a cross-sectional study. BMC Geriatr. 2022;22(1):681.CrossRefPubMedPubMedCentral Chang J, Hou W, Li Y, Li S, Zhao K, Wang Y, Hou Y, Sun Q. Prevalence and associated factors of cognitive frailty in older patients with chronic kidney disease: a cross-sectional study. BMC Geriatr. 2022;22(1):681.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Moriya M, Hu L, Sakatani K, Kitahara M. Estimation of cognitive impairment in chronic pain patients and characteristics of estimated mild cognitive impairment. Front Neurol. 2024;15:1344190.CrossRefPubMedPubMedCentral Moriya M, Hu L, Sakatani K, Kitahara M. Estimation of cognitive impairment in chronic pain patients and characteristics of estimated mild cognitive impairment. Front Neurol. 2024;15:1344190.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Tinnirello A, Mazzoleni S, Santi C. Chronic Pain in the Elderly: mechanisms and distinctive features. Biomolecules. 2021;11(8). Tinnirello A, Mazzoleni S, Santi C. Chronic Pain in the Elderly: mechanisms and distinctive features. Biomolecules. 2021;11(8).
6.
Zurück zum Zitat Duan W, Huang J, Huang Q, Dong B. Relationship between Pain and Dementia: the Mediating Effect of Depression among Chinese Elderly. Actas Esp Psiquiatr. 2024;52(2):114–21.CrossRefPubMedPubMedCentral Duan W, Huang J, Huang Q, Dong B. Relationship between Pain and Dementia: the Mediating Effect of Depression among Chinese Elderly. Actas Esp Psiquiatr. 2024;52(2):114–21.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Patnode CD, Perdue LA, Rossom RC, Rushkin MC, Redmond N, Thomas RG, Lin JS. Screening for cognitive impairment in older adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2020;323(8):764–85.CrossRefPubMed Patnode CD, Perdue LA, Rossom RC, Rushkin MC, Redmond N, Thomas RG, Lin JS. Screening for cognitive impairment in older adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2020;323(8):764–85.CrossRefPubMed
8.
Zurück zum Zitat Zhuang L, Yang Y, Gao J. Cognitive assessment tools for mild cognitive impairment screening. J Neurol. 2021;268(5):1615–22.CrossRefPubMed Zhuang L, Yang Y, Gao J. Cognitive assessment tools for mild cognitive impairment screening. J Neurol. 2021;268(5):1615–22.CrossRefPubMed
9.
Zurück zum Zitat Zhao L, Wang Y, Bawa EM, Meng Z, Wei J, Newman-Norlund S, Trivedi T, Hasturk H, Newman-Norlund RD, Fridriksson J, Merchant AT. Identifying a group of factors predicting cognitive impairment among older adults. PLoS ONE. 2024;19(4):e0301979.CrossRefPubMedPubMedCentral Zhao L, Wang Y, Bawa EM, Meng Z, Wei J, Newman-Norlund S, Trivedi T, Hasturk H, Newman-Norlund RD, Fridriksson J, Merchant AT. Identifying a group of factors predicting cognitive impairment among older adults. PLoS ONE. 2024;19(4):e0301979.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Huang Y, Huang Z, Yang Q, Jin H, Xu T, Fu Y, Zhu Y, Zhang X, Chen C. Predicting mild cognitive impairment among Chinese older adults: a longitudinal study based on long short-term memory networks and machine learning. Front Aging Neurosci. 2023;15:1283243.CrossRefPubMedPubMedCentral Huang Y, Huang Z, Yang Q, Jin H, Xu T, Fu Y, Zhu Y, Zhang X, Chen C. Predicting mild cognitive impairment among Chinese older adults: a longitudinal study based on long short-term memory networks and machine learning. Front Aging Neurosci. 2023;15:1283243.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat He CYY, Zhou Z, Kan MMP, Chan DHY, Wong ACT, Mok KHY, Lam FMH, Chan SCC, Cheung CKC, Yeung MKC, Wong AYL. Modifiable risk factors for mild cognitive impairment among cognitively normal community-dwelling older adults: a systematic review and meta-analysis. Ageing Res Rev. 2024;99:102350.CrossRefPubMed He CYY, Zhou Z, Kan MMP, Chan DHY, Wong ACT, Mok KHY, Lam FMH, Chan SCC, Cheung CKC, Yeung MKC, Wong AYL. Modifiable risk factors for mild cognitive impairment among cognitively normal community-dwelling older adults: a systematic review and meta-analysis. Ageing Res Rev. 2024;99:102350.CrossRefPubMed
12.
Zurück zum Zitat Jiang Y, Liu X, Gao H, Yan J, Cao Y. A new nomogram model for the individualized prediction of mild cognitive impairment in elderly patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2024;15:1307837.CrossRefPubMed Jiang Y, Liu X, Gao H, Yan J, Cao Y. A new nomogram model for the individualized prediction of mild cognitive impairment in elderly patients with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2024;15:1307837.CrossRefPubMed
13.
Zurück zum Zitat Xu W, Yang Q, Li L, Xiang Y, Yang Q. Construction and validation of a risk prediction model for mild cognitive impairment in Non-dialysis chronic kidney Disease Patient. Kidney Blood Press Res. 2024;49(1):556–80.CrossRefPubMed Xu W, Yang Q, Li L, Xiang Y, Yang Q. Construction and validation of a risk prediction model for mild cognitive impairment in Non-dialysis chronic kidney Disease Patient. Kidney Blood Press Res. 2024;49(1):556–80.CrossRefPubMed
14.
Zurück zum Zitat Andaur Navarro CL, Damen JAA, van Smeden M, Takada T, Nijman SWJ, Dhiman P, Ma J, Collins GS, Bajpai R, Riley RD, Moons KGM, Hooft L. Systematic review identifies the design and methodological conduct of studies on machine learning-based prediction models. J Clin Epidemiol. 2023;154:8–22.CrossRefPubMed Andaur Navarro CL, Damen JAA, van Smeden M, Takada T, Nijman SWJ, Dhiman P, Ma J, Collins GS, Bajpai R, Riley RD, Moons KGM, Hooft L. Systematic review identifies the design and methodological conduct of studies on machine learning-based prediction models. J Clin Epidemiol. 2023;154:8–22.CrossRefPubMed
15.
Zurück zum Zitat Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, Ghassemi M, Liu X, Reitsma JB, van Smeden M, Boulesteix AL, Camaradou JC, Celi LA, Denaxas S, Denniston AK, Glocker B, Golub RM, Harvey H, Heinze G, Hoffman MM, Kengne AP, Lam E, Lee N, Loder EW, Maier-Hein L, Mateen BA, McCradden MD, Oakden-Rayner L, Ordish J, Parnell R, Rose S, Singh K, Wynants L, Logullo P. TRIPOD + AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378.CrossRefPubMedPubMedCentral Collins GS, Moons KGM, Dhiman P, Riley RD, Beam AL, Van Calster B, Ghassemi M, Liu X, Reitsma JB, van Smeden M, Boulesteix AL, Camaradou JC, Celi LA, Denaxas S, Denniston AK, Glocker B, Golub RM, Harvey H, Heinze G, Hoffman MM, Kengne AP, Lam E, Lee N, Loder EW, Maier-Hein L, Mateen BA, McCradden MD, Oakden-Rayner L, Ordish J, Parnell R, Rose S, Singh K, Wynants L, Logullo P. TRIPOD + AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Nugraha B, Gutenbrunner C, Barke A, Karst M, Schiller J, Schäfer P, Falter S, Korwisi B, Rief W, Treede RD. The IASP classification of chronic pain for ICD-11: functioning properties of chronic pain. Pain. 2019;160(1):88–94.CrossRefPubMed Nugraha B, Gutenbrunner C, Barke A, Karst M, Schiller J, Schäfer P, Falter S, Korwisi B, Rief W, Treede RD. The IASP classification of chronic pain for ICD-11: functioning properties of chronic pain. Pain. 2019;160(1):88–94.CrossRefPubMed
17.
Zurück zum Zitat Ogundimu EO, Altman DG, Collins GS. Adequate sample size for developing prediction models is not simply related to events per variable. J Clin Epidemiol. 2016;76:175–82.CrossRefPubMedPubMedCentral Ogundimu EO, Altman DG, Collins GS. Adequate sample size for developing prediction models is not simply related to events per variable. J Clin Epidemiol. 2016;76:175–82.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–94.CrossRefPubMed Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–94.CrossRefPubMed
19.
Zurück zum Zitat Miao W, Lu Y, Xv H, Zheng C, Yang W, Qian X, Chen J, Geng G. Study protocol for a prediction model for mild cognitive impairment in older adults with diabetes mellitus and construction of a nurse-led screening system: a prospective observational study. BMJ Open. 2024;14(2):e075466.CrossRefPubMedPubMedCentral Miao W, Lu Y, Xv H, Zheng C, Yang W, Qian X, Chen J, Geng G. Study protocol for a prediction model for mild cognitive impairment in older adults with diabetes mellitus and construction of a nurse-led screening system: a prospective observational study. BMJ Open. 2024;14(2):e075466.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.CrossRefPubMed
21.
Zurück zum Zitat Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.CrossRefPubMed Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.CrossRefPubMed
22.
Zurück zum Zitat Carlsson AM. Assessment of chronic pain. I. aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16(1):87–101.CrossRefPubMed Carlsson AM. Assessment of chronic pain. I. aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16(1):87–101.CrossRefPubMed
23.
Zurück zum Zitat Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49.CrossRefPubMed Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49.CrossRefPubMed
24.
Zurück zum Zitat Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.CrossRefPubMed Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.CrossRefPubMed
25.
Zurück zum Zitat Jeon Y, Kim YJ, Jeon J, Nam KH, Hwang TS, Kim KG, Baek JH. Machine learning based prediction of recurrence after curative resection for rectal cancer. PLoS ONE. 2023;18(12):e0290141.CrossRefPubMedPubMedCentral Jeon Y, Kim YJ, Jeon J, Nam KH, Hwang TS, Kim KG, Baek JH. Machine learning based prediction of recurrence after curative resection for rectal cancer. PLoS ONE. 2023;18(12):e0290141.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, Li Y, Li Y, Zhu M, Jiao H, Song Y, Shi Y, Zhang H, Gong M, Wei C, Tang Y, Fang B, Guo D, Wang F, Zhou A, Chu C, Zuo X, Yu Y, Yuan Q, Wang W, Li F, Shi S, Yang H, Zhou C, Liao Z, Lv Y, Li Y, Kan M, Zhao H, Wang S, Yang S, Li H, Liu Z, Wang Q, Qin W, Jia J. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661–71.CrossRefPubMed Jia L, Du Y, Chu L, Zhang Z, Li F, Lyu D, Li Y, Li Y, Zhu M, Jiao H, Song Y, Shi Y, Zhang H, Gong M, Wei C, Tang Y, Fang B, Guo D, Wang F, Zhou A, Chu C, Zuo X, Yu Y, Yuan Q, Wang W, Li F, Shi S, Yang H, Zhou C, Liao Z, Lv Y, Li Y, Kan M, Zhao H, Wang S, Yang S, Li H, Liu Z, Wang Q, Qin W, Jia J. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health. 2020;5(12):e661–71.CrossRefPubMed
28.
Zurück zum Zitat Bachmann D, Buchmann A, Studer S, Saake A, Rauen K, Zuber I, Gruber E, Nitsch RM, Hock C, Gietl A, Treyer V. Age-, sex-, and pathology-related variability in brain structure and cognition. Transl Psychiatry. 2023;13(1):278.CrossRefPubMedPubMedCentral Bachmann D, Buchmann A, Studer S, Saake A, Rauen K, Zuber I, Gruber E, Nitsch RM, Hock C, Gietl A, Treyer V. Age-, sex-, and pathology-related variability in brain structure and cognition. Transl Psychiatry. 2023;13(1):278.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet. 2005;366(9496):1578–82.CrossRefPubMed Strong K, Mathers C, Leeder S, Beaglehole R. Preventing chronic diseases: how many lives can we save? Lancet. 2005;366(9496):1578–82.CrossRefPubMed
30.
Zurück zum Zitat Lövdén M, Fratiglioni L, Glymour MM, Lindenberger U, Tucker-Drob EM. Education and cognitive functioning across the Life Span. Psychol Sci Public Interest. 2020;21(1):6–41.CrossRefPubMedPubMedCentral Lövdén M, Fratiglioni L, Glymour MM, Lindenberger U, Tucker-Drob EM. Education and cognitive functioning across the Life Span. Psychol Sci Public Interest. 2020;21(1):6–41.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Chandra A, Dervenoulas G, Politis M. Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment. J Neurol. 2019;266(6):1293–302.CrossRefPubMed Chandra A, Dervenoulas G, Politis M. Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment. J Neurol. 2019;266(6):1293–302.CrossRefPubMed
32.
Zurück zum Zitat Zhao W, Zhao L, Chang X, Lu X, Tu Y. Elevated dementia risk, cognitive decline, and hippocampal atrophy in multisite chronic pain. Proc Natl Acad Sci U S A. 2023;120(9):e2215192120.CrossRefPubMedPubMedCentral Zhao W, Zhao L, Chang X, Lu X, Tu Y. Elevated dementia risk, cognitive decline, and hippocampal atrophy in multisite chronic pain. Proc Natl Acad Sci U S A. 2023;120(9):e2215192120.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Verdejo-García A, López-Torrecillas F, Calandre EP, Delgado-Rodríguez A, Bechara A. Executive function and decision-making in women with fibromyalgia. Arch Clin Neuropsychol. 2009;24(1):113–22.CrossRefPubMed Verdejo-García A, López-Torrecillas F, Calandre EP, Delgado-Rodríguez A, Bechara A. Executive function and decision-making in women with fibromyalgia. Arch Clin Neuropsychol. 2009;24(1):113–22.CrossRefPubMed
34.
Zurück zum Zitat Shipton E, Ponnamperuma D, Wells E, Trewin B. Demographic characteristics, psychosocial measures, and pain in a sample of patients with persistent pain referred to a New Zealand tertiary pain medicine center. Pain Med. 2013;14(7):1101–7.CrossRefPubMed Shipton E, Ponnamperuma D, Wells E, Trewin B. Demographic characteristics, psychosocial measures, and pain in a sample of patients with persistent pain referred to a New Zealand tertiary pain medicine center. Pain Med. 2013;14(7):1101–7.CrossRefPubMed
35.
Zurück zum Zitat Van der Mussele S, Fransen E, Struyfs H, Luyckx J, Mariën P, Saerens J, Somers N, Goeman J, De Deyn PP, Engelborghs S. Depression in mild cognitive impairment is associated with progression to Alzheimer’s disease: a longitudinal study. J Alzheimers Dis. 2014;42(4):1239–50.CrossRefPubMed Van der Mussele S, Fransen E, Struyfs H, Luyckx J, Mariën P, Saerens J, Somers N, Goeman J, De Deyn PP, Engelborghs S. Depression in mild cognitive impairment is associated with progression to Alzheimer’s disease: a longitudinal study. J Alzheimers Dis. 2014;42(4):1239–50.CrossRefPubMed
36.
Zurück zum Zitat Casagrande M, Forte G, Favieri F, Corbo I. Sleep Quality and Aging: A Systematic Review on Healthy Older People, Mild Cognitive Impairment and Alzheimer’s Disease. Int J Environ Res Public Health. 2022;19(14). Casagrande M, Forte G, Favieri F, Corbo I. Sleep Quality and Aging: A Systematic Review on Healthy Older People, Mild Cognitive Impairment and Alzheimer’s Disease. Int J Environ Res Public Health. 2022;19(14).
37.
Zurück zum Zitat Irwin MR, Vitiello MV. Implications of sleep disturbance and inflammation for Alzheimer’s disease dementia. Lancet Neurol. 2019;18(3):296–306.CrossRefPubMed Irwin MR, Vitiello MV. Implications of sleep disturbance and inflammation for Alzheimer’s disease dementia. Lancet Neurol. 2019;18(3):296–306.CrossRefPubMed
38.
Zurück zum Zitat Huang M, Gao X, Zhao R, Dong C, Gu Z, Gao J. Development and validation of a nomogram for predicting mild cognitive impairment in middle-aged and elderly people. Asian J Psychiatr. 2022;75:103224.CrossRefPubMed Huang M, Gao X, Zhao R, Dong C, Gu Z, Gao J. Development and validation of a nomogram for predicting mild cognitive impairment in middle-aged and elderly people. Asian J Psychiatr. 2022;75:103224.CrossRefPubMed
39.
Zurück zum Zitat Liang H, Fang Y. Chronic pain increases the risk of motoric cognitive risk syndrome at 4 years of follow-up: evidence from the China Health and Retirement Longitudinal Study. Eur J Neurol. 2023;30(4):831–8.CrossRefPubMed Liang H, Fang Y. Chronic pain increases the risk of motoric cognitive risk syndrome at 4 years of follow-up: evidence from the China Health and Retirement Longitudinal Study. Eur J Neurol. 2023;30(4):831–8.CrossRefPubMed
Metadaten
Titel
Explainable machine learning models for identifying mild cognitive impairment in older patients with chronic pain
verfasst von
Xiaoang Zhang
Yuping Liao
Daying Zhang
Weichen Liu
Zhijian Wang
Yaxin Jin
Shushu Chen
Jianmei Wei
Publikationsdatum
01.12.2025
Verlag
BioMed Central
Erschienen in
BMC Nursing / Ausgabe 1/2025
Elektronische ISSN: 1472-6955
DOI
https://doi.org/10.1186/s12912-025-02723-8